4//SEC Filing
Scranton Richard 4
Accession 0001209191-18-038202
CIK 0001396814other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 7:20 PM ET
Size
7.7 KB
Accession
0001209191-18-038202
Insider Transaction Report
Form 4
Scranton Richard
Chief Scientific Officer
Transactions
- Award
Common Stock
2018-06-13+7,875→ 20,101 total - Award
Stock Option (Right to Buy)
2018-06-13+47,250→ 47,250 totalExercise: $38.35Exp: 2028-06-13→ Common Stock (47,250 underlying)
Footnotes (2)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2019, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira Pharmaceuticals, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001709330
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 7:20 PM ET
- Size
- 7.7 KB